Real-world treatment pattern and comprehensive comparative effectiveness of Endostar plus different chemotherapy in advanced patients with non-small cell lung cancer

Recombinant human endostatin (Endostar) plus vinorelbine/cisplatin (NP) had been approved for the treatment of non-small cell lung cancers (NSCLC). But the real-world treatment pattern and effectiveness of Endostar plus other combination chemotherapy, namely docetaxel/platinum (DP), gemcitabine/plat...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Wei, Sun, Wei, Li, Wenhui, Gao, Jin, Wang, Hui, Zhou, Wei, Liang, Jing, Aa, Lixiang, Wang, Luhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237081/
https://www.ncbi.nlm.nih.gov/pubmed/35761010
http://dx.doi.org/10.1038/s41598-022-14222-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237081/
https://www.ncbi.nlm.nih.gov/pubmed/35761010
http://dx.doi.org/10.1038/s41598-022-14222-w

Ejemplares similares